Biography:Nabil F. Saba

From HandWiki
Nabil F. Saba
Saba Nabil.jpg
Alma mater
  • American University of Beirut
Awards
  • Received Distinguished Doctor (2015)[1]
Scientific career
InstitutionsEmory University
Website

Nabil F. Saba is an oncologist and professor of hematology and medical oncology at Emory University School of Medicine in Atlanta, Georgia.[2] He has authored more than 150 peer-reviewed articles and is an elected member of the American Head and Neck Society (AHNS).[3]

Research and career

Nabil Saba earned a B.S. in chemistry at the American University of Beirut in Lebanon, completed his medical degree from the American University of Beirut Medical school.[4]

Saba researched the relationship between radiation dose and overall survival in Cervical esophageal cancer.[5][6] He also conducted research on the peritumoral vasculature in head and neck cancer, revealing that patients with metastatic disease were more likely to have high peritumoral blood microvessel density (MVD).[7]

Saba was an assistant professor in the Department of Hematology and Oncology, and served as the director of house staff education programs at the Winship Cancer Institute of Emory University.[8] During his tenure at Emory University School of Medicine, he served in different positions including Hematology and Medical oncology Professor, Otolaryngology Professor, also lending his services at the Winship Cancer Institute of Emory University as the director of the Head and Neck Medical Oncology Program.[9][10]

Memberships and awards

Saba won numerous awards including Distinguished Doctor (2015), Atlanta Magazine’s Top Doctors (2005, 2016-2018), Outstanding reviewer for journal of cancer (2017), Castle Connolly Top Doctors (2011, 2014), Recognition for outstanding contribution to the Fellowship program (2003), and Top Docs in Atlanta (2005).[11][12][13]

Saba is a member of numerous professional organizations including the American College of Radiology, American College of physicians, American Society of Clinical Oncology, and Massachusetts Medical Society.[14]

Publications

  • N Saba, DM Sutton, HJ Ross, S Siu, RM Crump, A Keating & AK Stewart. "High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant". Journal of Bone Marrow transplantation.[15]
  • Saba N.F, Goodman M, Ward K, Flowers C, Ramalingam S, Owonikoko T, Chen A, Grist W, Wadsworth T, Beitler J.J, Khuri F.R, and Shin D.M. "Gender and Ethnic Disparities in Incidence and Survival of Squamous Cell Carcinoma of the Oral Tongue, Base of Tongue, and Tonsils: A Surveillance, Epidemiology and End Results Program-Based Analysis". Journal of Oncology.[16]
  • Saba NF, Hurwitz SJ, Kono SA, Yang CS, Zhao Y, Chen Z, Sica G, Müller S, Moreno-Williams R, Lewis M, Grist W, Chen AY, Moore CE, Owonikoko TK, Ramalingam S, Beitler JJ, Nannapaneni S, Shin HJ, Grandis JR, Khuri FR, Chen ZG, Shin DM. "Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study". Cancer Prevention Research.[17]
  • Saba NF, Wang X, Müller S, Tighiouart M, Cho K, Nie S, Chen Z, Shin DM. "Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug". Journal of the Sciences and Specialties of the Head and Neck.[18]
  • Saba NF, Choi M, Muller S, Shin HJ, Tighiouart M, Papadimitrakopoulou VA, El-Naggar AK, Khuri FR, Chen ZG, Shin DM. "Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma". Journal of Cancer Prevention Research.[19]

References

  1. ↑ "Naba Sabil". https://winshipcancer.emory.edu/bios/faculty/saba-nabil.html. 
  2. ↑ "Profile | Emory School of Medicine". https://med.emory.edu/directory/profile/?u=NFSABA. 
  3. ↑ "nabil saba - Google Scholar Citations". https://scholar.google.com/citations?user=ounMfoUAAAAJ&hl=en. 
  4. ↑ "emory.edu". http://whsc.emory.edu/_releases/2003july/saba.html. 
  5. ↑ Saba, N.; Sutton, D. M.; Ross, H. J.; Siu, S.; Crump, R. M.; Keating, A.; Stewart, A. K. (October 1999). "High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant". Bone Marrow Transplantation 24 (8): 853–855. doi:10.1038/sj.bmt.1702005. ISSN 1476-5365. PMID 10516696. 
  6. ↑ Patel, P. R.; McDonald, M. W.; Aiello, A.; Liu, Y.; Saba, N. F.; Beitler, J. J.; Higgins, K. A. (2017-10-01). "The Relationship Between Radiation Dose And Overall Survival In Cervical Esophageal Cancer: An NCDB Analysis" (in English). International Journal of Radiation Oncology • Biology • Physics 99 (2): E178–E179. doi:10.1016/j.ijrobp.2017.06.1029. ISSN 0360-3016. https://www.redjournal.org/article/S0360-3016(17)32083-7/abstract. 
  7. ↑ Evans, Michael; Jr, Harry Michael Baddour; Magliocca, Kelly R.; Müller, Susan; Nannapaneni, Sreenivas; Chen, Amy Y.; Kim, Sunjin; Chen, Zhengjia et al. (2019). "Prognostic implications of peritumoral vasculature in head and neck cancer". Cancer Medicine 8 (1): 147–154. doi:10.1002/cam4.1910. ISSN 2045-7634. PMID 30575303. 
  8. ↑ "emory.edu". http://whsc.emory.edu/_releases/2003july/saba.html. 
  9. ↑ "Dr. Nabil F Saba, MD, FACP - Atlanta, GA - Medical Oncology - Request Appointment". https://providers.emoryhealthcare.org/provider/Nabil+F+Saba/777822?_ga=2.101257346.2097480911.1568098166-536955398.1567836438. 
  10. ↑ "Nabil F. Saba, MD, FACP". https://winshipcancer.emory.edu/%0A%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20/bios/faculty/saba-nabil. 
  11. ↑ "Nabil F. Saba, M.D. - Noticed". https://noticed.co/members/nabil-f-saba,-md/3d9d03ad01515f38. 
  12. ↑ "Profile | Emory School of Medicine". https://med.emory.edu/directory/profile/?u=NFSABA. 
  13. ↑ "Nabil F. Saba, MD, FACP". https://winshipcancer.emory.edu/%0A%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20/bios/faculty/saba-nabil. 
  14. ↑ "Dr. Nabil F Saba, MD, FACP - Atlanta, GA - Medical Oncology - Request Appointment". https://providers.emoryhealthcare.org/provider/Nabil+F+Saba/777822?_ga=2.101257346.2097480911.1568098166-536955398.1567836438. 
  15. ↑ Saba, N.; Sutton, D. M.; Ross, H. J.; Siu, S.; Crump, R. M.; Keating, A.; Stewart, A. K. (1999). "High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant". Bone Marrow Transplantation 24 (8): 853–855. doi:10.1038/sj.bmt.1702005. ISSN 1476-5365. 
  16. ↑ Saba, Nabil F.; Goodman, Michael; Ward, Kevin; Flowers, Chris; Ramalingam, Suresh; Owonikoko, Taofeek; Chen, Amy; Grist, William et al. (2011). "Gender and Ethnic Disparities in Incidence and Survival of Squamous Cell Carcinoma of the Oral Tongue, Base of Tongue, and Tonsils: A Surveillance, Epidemiology and End Results Program-Based Analysis" (in english). Oncology 81 (1): 12–20. doi:10.1159/000330807. ISSN 0030-2414. PMID 21912193. 
  17. ↑ Saba, Nabil F.; Hurwitz, Selwyn J.; Kono, Scott A.; Yang, Chung S.; Zhao, Yang; Chen, Zhengjia; Sica, Gabe; Müller, Susan et al. (March 2014). "Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study". Cancer Prevention Research (Philadelphia, Pa.) 7 (3): 283–291. doi:10.1158/1940-6207.CAPR-13-0215. ISSN 1940-6215. PMID 24085777. 
  18. ↑ Saba, Nabil F.; Wang, Xu; Müller, Susan; Tighiouart, Mourad; Cho, Kwangjae; Nie, Shuming; Chen, Zhuo (Georgia); Shin, Dong M. (2009). "Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug". Head & Neck 31 (4): 475–481. doi:10.1002/hed.21003. ISSN 1097-0347. PMID 19072997. 
  19. ↑ Saba, Nabil F.; Choi, Misun; Muller, Susan; Shin, Hyung Ju C.; Tighiouart, Mourad; Papadimitrakopoulou, Vassiliki A.; El-Naggar, Adel K.; Khuri, Fadlo R. et al. (2009). "Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma". Cancer Prevention Research (Philadelphia, Pa.) 2 (9): 823–829. doi:10.1158/1940-6207.CAPR-09-0077. ISSN 1940-6215. PMID 19737986. 




Retrieved from "https://handwiki.org/wiki/index.php?title=Biography:Nabil_F._Saba&oldid=819466"